Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

Masood A. Shammas, Robert J. Shmookler Reis, Hemanta Koley, Ramesh B. Batchu, Cheng Li, Nikhil C. Munshi

Blood (2009) 113 (10): 2290–2297.

https://doi.org/10.1182/blood-2007-05-089193

Published: 2009

Journal Articles

Biological Pathways and In Vivo Anti-Tumor Activity Induced by Atiprimod in Multiple Myeloma (MM).

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood Shammas, PhD, Hiroshi Yasui, MD, Ernestina Schipani, MD, Ramesh B. Batchu, PhD, Simona Blotta, MD, Rao Prabhala, PhD, Laurence Catley, MD, Makoto Hamasaki, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Gary S. Jacob, PhD, Donald Picker, PhD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 3455.

https://doi.org/10.1182/blood.V108.11.3455.3455

Published: 2006

Journal Articles

Elevated Apurinic/Apyrimidinic Endonuclease Activity Significantly Contributes to DNA Instability in Multiple Myeloma.

Masood A. Shammas, PhD, Robert C. Bertheau, Hemanta Koley, PhD, Paola Neri, MD, Pierfrancesco Tassone, MD, Ramesh B. Batchu, PhD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 2077.

https://doi.org/10.1182/blood.V108.11.2077.2077

Published: 2006

Journal Articles

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

Masood A. Shammas, Paola Neri, Hemanta Koley, Ramesh B. Batchu, Robert C. Bertheau, Vidit Munshi, Rao Prabhala, Mariateresa Fulciniti, Yu tzu Tai, Steven P. Treon, Raj K. Goyal, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2006) 108 (8): 2804–2810.

https://doi.org/10.1182/blood-2006-05-022814

Published: 2006

Journal Articles

In Vivo Anti-Tumor Activity of Atiprimod on SCID Models of Multiple Myeloma.

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood A. Shammas, PhD, Ramesh B. Batchu, PhD, Simona Blotta, MD, Sushma Samala, PhD, Laurence Catley, MD, Makoto Hamasaki, PhD, Teru Hideshima, MD, Gary S. Jacob, PhD, Donald H. Picker, PhD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 249.

https://doi.org/10.1182/blood.V106.11.249.249

Published: 2005

Journal Articles

Molecular Basis of Genomic Instability and Progression in Multiple Myeloma: Potential Role of Apurinic (Apyrimidinic) Endonuclease.

Masood A. Shammas, PhD, Hemanta Koley, PhD, Paola Neri, MD, Pierfrancesco Tassone, MD, Ramesh B. Batchu, PhD, Robert Bertheau, Robert J. Shmookler Reis, PhD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 1561.

https://doi.org/10.1182/blood.V106.11.1561.1561

Published: 2005

Journal Articles

A Green Tea Polyphenol, Epigallocatechin-3-Gallate, Induces Selective Apoptosis in Multiple Myeloma Cells: Mechanism of Action and Therapeutic Potential.

Masood A. Shammas, PhD, Ramesh B. Batchu, PhD, Hemanta Koley, PhD, Robert C. Bertheau, Paola Neri, MD, Raj Goyal, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 1590.

https://doi.org/10.1182/blood.V106.11.1590.1590

Published: 2005

Journal Articles

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Frits van Rhee, Susann M. Szmania, Fenghuang Zhan, Sushil K. Gupta, Mindy Pomtree, Pei Lin, Ramesh B. Batchu, Amberly Moreno, Guilio Spagnoli, John Shaughnessy, Guido Tricot

Blood (2005) 105 (10): 3939–3944.

https://doi.org/10.1182/blood-2004-09-3707

Published: 2005

Journal Articles

Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.

Masood A. Shammas, PhD, Hemanta Koley, PhD, Ramesh B. Batchu, PhD, Paola Neri, PhD, Pierfrancesco Tassone, PhD, Rao Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 2461.

https://doi.org/10.1182/blood.V104.11.2461.2461

Published: 2004

Journal Articles

Dysregulated Apurinic/Apyrimidinic Endonucleases (Ape1 and Ape2) Lead to Genetic Instability in Multiple Myeloma.

Masood A. Shammas, PhD, Hemant Koley, PhD, Sima Shah, BS, Ramesh B. Batchu, PhD, Pierfrancesco Tassone, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 1418.

https://doi.org/10.1182/blood.V104.11.1418.1418

Published: 2004

NARROW

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

Biological Pathways and In Vivo Anti-Tumor Activity Induced by Atiprimod in Multiple Myeloma (MM).

Elevated Apurinic/Apyrimidinic Endonuclease Activity Significantly Contributes to DNA Instability in Multiple Myeloma.

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

In Vivo Anti-Tumor Activity of Atiprimod on SCID Models of Multiple Myeloma.

Molecular Basis of Genomic Instability and Progression in Multiple Myeloma: Potential Role of Apurinic (Apyrimidinic) Endonuclease.

A Green Tea Polyphenol, Epigallocatechin-3-Gallate, Induces Selective Apoptosis in Multiple Myeloma Cells: Mechanism of Action and Therapeutic Potential.

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.

Dysregulated Apurinic/Apyrimidinic Endonucleases (Ape1 and Ape2) Lead to Genetic Instability in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only